EUVIMEDEUVIMED entdecken
Crossref

Respiratory cross-infection in non-invasive ventilation devices

G T P Tay, K Smith, C He, B Dyer, R M Thomson, D W Reid, L Morawska, S C Bell

Journal of Hospital Infection · 2026-07 · 173 · 154-163

DOI: 10.1016/j.jhin.2026.04.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hospital Infection, 2026-07. Verfasst von G T P Tay und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Medicine, The Prince Charles Hospital (TPCH), Chermside, Queensland, Australia; Department of Respiratory and Sleep Medicine, …. Hauptthemen laut MEDLINE: Noninvasive Ventilation, Cross Infection, Respiratory Tract Infections. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Queensland University of Technology, Cystic Fibrosis Foundation Therapeutics Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Non-invasive ventilation (NIV) is considered an aerosol-generating procedure (AGP), yet the extent of the risk of airborne pathogen transmission remains uncertain. To address this, we conducted three studies assessing bioaerosol generation, device contamination, and cough-related dispersion during NIV. METHOD: Studies 1 and 2 used a purpose-designed rig with high-efficiency particulate air (HEPA)-filtered supply flow, ensuring detection of particles generated only by the NIV system. Study 3 uses a flow-tunnel rig to compare aerosol dispersion during NIV, sham NIV, tidal breathing, and uncovered coughing. RESULT: In the controlled laboratory setting (study 1), NIV-generated aerosol particles were measured. Viable Pseudomonas aeruginosa was detected when inoculum concentrations were ≥1 × 105 colony-forming unit (cfu)/mL, and the use of inline antibacterial filters prevented bacterial emission. Study 2 demonstrated low risk of NIV device contamination (1 in 10) during short-term use. While in study 3, NIV with therapeutic pressure generated higher physical aerosol counts than tidal breathing or sham NIV but less than that with uncovered coughing. Among 13 participants, viable pathogens were detected in uncovered coughs from seven (54%) participants (median: 9, interquartile range: 3-12 cfu), while only one participant had a positive result during NIV (2 cfu with sham and 3 cfu with therapeutic NIV). CONCLUSION: Our findings demonstrate that NIV devices may be contaminated after use and can aerosolize viable bacteria. While the World Health Organization classifies NIV as a high-risk AGP, we demonstrate low likelihood of infectious particle release, particularly when effective interfaces, leak control, and robust infection prevention measures are implemented.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Noninvasive VentilationCross InfectionRespiratory Tract InfectionsHumansAerosolsPseudomonas aeruginosa

Stichwörter der Autor:innen

Airborne pathogen transmissionBioaerosolsDevice contaminationNon-invasive ventilationRespiratory cross-infection

Substanzen

Aerosols

Autor:innen und Institutionen

  • Department of Thoracic Medicine, The Prince Charles Hospital (TPCH), Chermside, Queensland, Australia; Department of Respiratory and Sleep Medicine, Gold Coast University Hospital (GCUH), Southport, Queensland, Australi…
  • Child Health Research Centre, The University of Queensland, Brisbane, Queensland, Australia; Queensland Mycobacterium Reference Laboratory, Brisbane, Queensland, Australia.
  • International Laboratory for Air Quality and Health (ILAQH), School of Earth and Atmospheric Sciences, Queensland University of Technology (QUT), Brisbane, Queensland, Australia.
  • Griffith Biostatistics Unit, Griffith Health, Griffith University, Southport, Queensland, Australia.
  • Department of Thoracic Medicine, The Prince Charles Hospital (TPCH), Chermside, Queensland, Australia; Greenslopes Clinical School, Gallipoli Medical Research, The University of Queensland, Greenslopes, Queensland, Aust…
  • Department of Thoracic Medicine, The Prince Charles Hospital (TPCH), Chermside, Queensland, Australia; Lung Inflammation and Infection Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Austral…

Förderung

  • Queensland University of Technology
  • Cystic Fibrosis Foundation Therapeutics Inc

Zitieren

APA

Tay, G. T. P., Smith, K., He, C., Dyer, B., Thomson, R. M., Reid, D. W., Morawska, L., & Bell, S. C. (2026). Respiratory cross-infection in non-invasive ventilation devices. Journal of Hospital Infection, 173, 154-163. https://doi.org/10.1016/j.jhin.2026.04.021

Vancouver

Tay GTP, Smith K, He C, Dyer B, Thomson RM, Reid DW, et al. Respiratory cross-infection in non-invasive ventilation devices. Journal of Hospital Infection. 2026;173:154-163. doi:10.1016/j.jhin.2026.04.021

BibTeX
@article{Tay2026,
  author = {Tay, G T P and Smith, K and He, C and Dyer, B and Thomson, R M and Reid, D W and Morawska, L and Bell, S C},
  title = {Respiratory cross-infection in non-invasive ventilation devices},
  journal = {Journal of Hospital Infection},
  year = {2026},
  volume = {173},
  pages = {154--163},
  doi = {10.1016/j.jhin.2026.04.021}
}
Kostenlos starten →